Comparison of the Outcomes of Photodynamic Therapy between Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

Publisher： Karger

E-ISSN： 1423-0267|232|2|92-96

ISSN： 0030-3755

Source： Ophthalmologica, Vol.232, Iss.2, 2014-06, pp. : 92-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the 12-Month Outcomes of Intravitreal Ranibizumab between Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 237, Iss. 3, 2017-03 ,pp. : 123-127

Karger

Access to resources Recommend Favorite

Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula

By  

Ophthalmologica, Vol. 218, Iss. 3, 2004-04 ,pp. : 193-201

Karger

Access to resources Recommend Favorite

Two-Year Outcome after Combination Therapy for Polypoidal Choroidal Vasculopathy: Comparison with Photodynamic Monotherapy and Anti-Vascular Endothelial Growth Factor Monotherapy

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-10 ,pp. : 86-93

Karger

Access to resources Recommend Favorite

The Association of Age-related Maculopathy Susceptibility 2 (ARMS2) and Complement Factor H (CFH) Variants with Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

By Miki Akiko   Honda Shigeru   Kondo Naoshi   Negi Akira  

Ophthalmic Genetics, Vol. 34, Iss. 3, 2013-09 ,pp. : 146-150

Informa Healthcare

Access to resources Recommend Favorite

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 4, 2011-09 ,pp. : 205-213

Karger

Access to resources Recommend Favorite